Natera Gross Profit 2014-2025 | NTRA
Natera annual/quarterly gross profit history and growth rate from 2014 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Natera gross profit for the quarter ending March 31, 2025 was $0.317B, a 51.85% increase year-over-year.
- Natera gross profit for the twelve months ending March 31, 2025 was $1.131B, a 86.16% increase year-over-year.
- Natera annual gross profit for 2024 was $1.023B, a 107.65% increase from 2023.
- Natera annual gross profit for 2023 was $0.493B, a 35.38% increase from 2022.
- Natera annual gross profit for 2022 was $0.364B, a 18.53% increase from 2021.
| Natera Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $1,023 |
| 2023 | $493 |
| 2022 | $364 |
| 2021 | $307 |
| 2020 | $187 |
| 2019 | $127 |
| 2018 | $92 |
| 2017 | $70 |
| 2016 | $77 |
| 2015 | $78 |
| 2014 | $81 |
| 2013 | $18 |
| Natera Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-03-31 | $317 |
| 2024-12-31 | $300 |
| 2024-09-30 | $272 |
| 2024-06-30 | $243 |
| 2024-03-31 | $209 |
| 2023-12-31 | $160 |
| 2023-09-30 | $121 |
| 2023-06-30 | $118 |
| 2023-03-31 | $94 |
| 2022-12-31 | $90 |
| 2022-09-30 | $94 |
| 2022-06-30 | $89 |
| 2022-03-31 | $91 |
| 2021-12-31 | $79 |
| 2021-09-30 | $77 |
| 2021-06-30 | $66 |
| 2021-03-31 | $86 |
| 2020-12-31 | $52 |
| 2020-09-30 | $46 |
| 2020-06-30 | $40 |
| 2020-03-31 | $49 |
| 2019-12-31 | $39 |
| 2019-09-30 | $34 |
| 2019-06-30 | $31 |
| 2019-03-31 | $24 |
| 2018-12-31 | $24 |
| 2018-09-30 | $24 |
| 2018-06-30 | $22 |
| 2018-03-31 | $22 |
| 2017-12-31 | $15 |
| 2017-09-30 | $21 |
| 2017-06-30 | $18 |
| 2017-03-31 | $16 |
| 2016-12-31 | $7 |
| 2016-09-30 | $20 |
| 2016-06-30 | $21 |
| 2016-03-31 | $30 |
| 2015-12-31 | $21 |
| 2015-09-30 | $14 |
| 2015-06-30 | $19 |
| 2015-03-31 | $23 |
| 2014-12-31 | |
| 2014-09-30 | $25 |
| 2014-06-30 | $17 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $20.836B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.350B | 26.32 |
| Elevance Health (ELV) | United States | $91.117B | 11.76 |
| CVS Health (CVS) | United States | $79.102B | 9.83 |
| Cencora (COR) | United States | $56.251B | 19.57 |
| DiDi Global (DIDIY) | China | $21.979B | 33.36 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.822B | 13.57 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.604B | 0.00 |
| CochLear (CHEOY) | Australia | $11.282B | 0.00 |
| Revvity (RVTY) | United States | $10.993B | 18.92 |
| ICON (ICLR) | Ireland | $10.630B | 9.88 |
| Viatris (VTRS) | United States | $10.375B | 3.56 |
| Doximity (DOCS) | United States | $9.813B | 45.70 |
| Avantor (AVTR) | United States | $9.138B | 13.28 |
| Medpace Holdings (MEDP) | United States | $8.785B | 23.33 |
| HealthEquity (HQY) | United States | $8.497B | 41.80 |
| Sonic Healthcare (SKHHY) | Australia | $8.220B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.924B | 13.57 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.257B | 39.40 |
| Bausch + Lomb (BLCO) | Canada | $4.156B | 24.50 |
| Sotera Health (SHC) | United States | $3.633B | 20.65 |
| Alignment Healthcare (ALHC) | United States | $3.122B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.068B | 39.90 |
| Concentras Parent (CON) | United States | $2.912B | 16.83 |
| Organon (OGN) | United States | $2.350B | 2.50 |
| Ardent Health Partners (ARDT) | United States | $2.204B | 9.40 |
| GeneDx Holdings (WGS) | United States | $1.949B | 75.07 |
| Progyny (PGNY) | United States | $1.912B | 42.08 |
| Premier (PINC) | United States | $1.904B | 14.45 |
| PACS (PACS) | United States | $1.647B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.414B | 28.29 |
| Teladoc Health (TDOC) | United States | $1.319B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.283B | 9.76 |
| Establishment Labs Holdings (ESTA) | $1.046B | 0.00 | |
| Agilon Health (AGL) | United States | $1.014B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 15.25 |
| Nutex Health (NUTX) | United States | $0.972B | 14.69 |
| AMN Healthcare Services Inc (AMN) | United States | $0.869B | 8.13 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.702B | 4.73 |
| InnovAge Holding (INNV) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.539B | 44.33 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.63 |
| Sonida Senior Living (SNDA) | United States | $0.494B | 0.00 |
| LifeMD (LFMD) | United States | $0.487B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.370B | 0.00 |
| SBC Medicals (SBC) | United States | $0.352B | 0.00 |
| Oncology Institute (TOI) | United States | $0.226B | 0.00 |
| Beauty Health (SKIN) | United States | $0.218B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.209B | 0.00 |
| DocGo (DCGO) | United States | $0.150B | 24.50 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| KindlyMD (KDLY) | United States | $0.078B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |